Pulmonary Arterial Hypertension in Women

Humna Abid Memon; Myung H. Park

doi:10.14797/mdcj-13-4-224

Pulmonary Arterial Hypertension in Women

Methodist DeBakey Cardiovascular Journal

Volume 13 (2017): Issue 4

By: Humna Abid Memon and Myung H. Park

Open Access

|Oct 2017

Abstract

Pulmonary arterial hypertension (PAH) is characterized by pathological hemodynamic elevation in pulmonary artery pressure. Development of international registries over the last decade has raised awareness about the disease, leading to the development of new and improved therapies. Paradigm shifts such as these warrant review of existing literature regarding PAH, especially in females, as the disease continues to affect women more than males. The aim of this review is to provide an update on the classification, pathophysiology, diagnosis, and treatment of PAH while focusing specifically on its impact on women.

References

Kovacs G , Berghold A , Scheidl S , Olschewski H. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J. 2009 Oct; 34 4: 888– 94.
Search in Google Scholar Back to article
Hoeper MM , Bogaard HJ , Condliffe R , Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol. 2013 Dec 24; 62 25 Suppl: D42– D50.
Search in Google Scholar Back to article
Hatano S Strasser T. Primary Pulmonary Hypertension. Report on a WHO meeting. World Health Organization meeting; 1973 Oct 15–17; Geneva, Switzerland.
Search in Google Scholar Back to article
Simonneau G , Gatzoulis MA , Adatia I , Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013 Dec 24; 62 25 Suppl: D34– D41.
Search in Google Scholar Back to article
Peacock AJ , Murphy NF , McMurray JJ , Caballero L , Stewart S. An epidemiological study of pulmonary arterial hypertension. Eur Respir J. 2007 Jul; 30 1: 104– 9.
Search in Google Scholar Back to article
Humbert M , Sitbon O , Chaouat A , Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med. 2006 May 1; 173 9: 1023– 30.
Search in Google Scholar Back to article
Jansa P , Jarkovsky J , Al-Hiti H , Epidemiology and long term survival of pulmonary arterial hypertension in the Czech Republic: a retrospective analysis of a nationwide registry. BMC Pulm Med. 2014 Mar 15; 14: 45.
Search in Google Scholar Back to article
Rich S , Dantzker DR , Ayres SM , Primary pulmonary hypertension. A national prospective surgery. Ann Intern Med. 1987 Aug; 107 2: 216– 23.
Search in Google Scholar Back to article
Badesch DB , Raskob GE , Elliot CG , Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest. 2010 Feb; 137 2: 376– 87.
Search in Google Scholar Back to article
Frost AE , Badesch DB , Barst RJ , The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US contemporary registries. Chest. 2011 Jan; 139 1: 128– 37.
Search in Google Scholar Back to article
Hoeper MM , Huscher D , Ghofrani HA , Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry. Int J Cardiol. 2013 Sep 30; 168 2: 871– 80.
Search in Google Scholar Back to article
Chung L , Farber HW , Benza R , Unique predictors of mortality in patients with pulmonary arterial hypertension associated with systemic sclerosis in the REVEAL registry. Chest. 2014 Dec; 146 6: 1494– 504.
Search in Google Scholar Back to article
Farber HW , Miller DP , Poms AD , Five-year outcomes of patients enrolled in the REVEAL registry. Chest. 2015 Oct; 148 4: 1043– 54.
Search in Google Scholar Back to article
Benza RL , Miller DP , Gomberg MM , Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation. 2010 Jul 13; 122 2: 164– 72.
Search in Google Scholar Back to article
Humbert M , Sitbon O , Chaouat A , Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation. 2010 Jul 13; 122 2: 156– 63.
Search in Google Scholar Back to article
Pletra GG , Capron F , Stewart S , Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol. 2004 Jun 16; 43 12 Suppl S: 25S– 32S.
Search in Google Scholar Back to article
Voelkel NF , Tuder RM , Weir EK. Pathophysiology of primary pulmonary hypertension. In: Rubin L , Rich S , editors. Primary pulmonary hypertension. New York: Marcel Dekker; 1997. p. 83– 129.
Search in Google Scholar Back to article
Farber HW Loscalzo J. Pulmonary arterial hypertension. N Engl J Med. 2004 Oct 14; 351 16: 1655– 65.
Search in Google Scholar Back to article
Christman BW , McPherson CD , Newman JH , An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med. 1992 Jul 9; 327 2: 70– 5.
Search in Google Scholar Back to article
Stewart DJ , Levy RD , Cernacek P , Langleben D. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann Intern Med. 1991 Mar; 114 6: 464– 9.
Search in Google Scholar Back to article
Ghofrani HA , Pepke-Zaba J , Barbera JA , Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension. J Am Coll Cardiol. 2004 Jun 16; 43 12 Suppl S: 68S– 72S.
Search in Google Scholar Back to article
Glaid A , Yanagisawa M , Langleben D , Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med. 1993 Jun 17; 328 24: 1732– 9.
Search in Google Scholar Back to article
Vincent JA , Ross RD , Kassab J , Hsu JM , Pinsky WW. Relation of elevated plasma endothelin in congenital heart disease to increased pulmonary blood flow. Am J Cardiol. 1993 May 15; 71 13: 1204– 7.
Search in Google Scholar Back to article
Steiner MK , Syrkina OL , Kolliputi N , Mark EJ , Hales CA , Waxman AB. Interleukin-6 overexpression induces pulmonary hypertension. Circ Res. 2009 Jan 30; 104 2: 236– 44.
Search in Google Scholar Back to article
Loyd JE , Primm RK , Newman JH. Familial primary pulmonary hypertension: clinical patterns. Am Rev Respir Dis. 1984 Jan; 129 1: 194– 7.
Search in Google Scholar Back to article
Fessel J , Loyd J , Austin E. The genetics of pulmonary arterial hypertension in the post-BMPR2 era. Pulm Circ. 2011 Jul–Sep; 1 3: 305– 19.
Search in Google Scholar Back to article
Trembath R , Thomson J , Machado R , Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med. 2001 Aug 2; 345 5: 325– 34.
Search in Google Scholar Back to article
Umar S , Rabinovitch , Eghbali . Estrogen Paradox in Pulmonary Hypertension. Am J Resp Crit Care Med. 2012 Jul 15; 186 2: 125– 31.
Search in Google Scholar Back to article
Austin ED , Hamid R , Hemnes AR , BMPR2 expression is suppressed by signaling through the estrogen receptor. Biol Sex Differ. 2012 Feb 20; 3 1: 6.
Search in Google Scholar Back to article
Atkinson C , Stewart S , Upton PD , Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor. Circulation. 2002 Apr 9; 105 14: 1672– 8.
Search in Google Scholar Back to article
Boggaard HJ , Abe K , Vonk Noordegraaf A , Voelkel NF. The right ventricle under pressure: cellular and molecular mechanisms of right heart failure in pulmonary circulation. Chest. 2009 Mar; 135 3: 794– 804.
Search in Google Scholar Back to article
Aguero J , Ishikawa K , Hadri L , Characterization of right ventricular remodeling and failure in a chronic pulmonary hypertension model. Am J Physiol Heart Circ Physiol. 2014 Oct 15; 307 8: H1204– 15.
Search in Google Scholar Back to article
McLaughlin VV , Archer SL , Badesch DB , ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol. 2009 Apr 28; 53 17: 1573– 619.
Search in Google Scholar Back to article
Sciomer S , Badagliacca R , Fedele F. Pulmonary hypertension: echocardiographic assessment. Ital Heart J. 2005; 6: 840– 5.
Search in Google Scholar Back to article
Bossone E , Duong-Wagner TH , Paciocco G , Echocardiographic features of primary pulmonary hypertension. J Am Soc Echocardiogr. 1999 Aug; 12 8: 655– 62.
Search in Google Scholar Back to article
Ling LF Marwick TH. Echocardiographic assessment of right ventricular function: How to account for tricuspid regurgitation and pulmonary hypertension. JACC Cardiovasc Imaging. 2012 Jul; 5 7: 747– 53.
Search in Google Scholar Back to article
Galiè N , Humbert M , Vachiery JL , 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015 Oct; 46 4: 903– 75.
Search in Google Scholar Back to article
Ryan JJ , Rich JD , Thiruvoipati T , Swamy R , Kim GH , Rich S. Current practice for determining pulmonary capillary wedge pressure predisposes to serious errors in the classification of patients with pulmonary hypertension. Am Heart J. 2012 Apr; 163 4: 589– 94.
Search in Google Scholar Back to article
Tonelli AR , Alnuaimat H , Mubarak K. Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension. Respir Med. 2010 Apr; 104 4: 481– 96.
Search in Google Scholar Back to article
Barnett CF , Alvarez P , Park MH. Pulmonary Arterial Hypertension: Diagnosis and Treatment. Cardiol Clin. 2016 Aug; 34 3: 375– 89.
Search in Google Scholar Back to article
Boxt LM Katz J. Magnetic resonance imaging for quantitation of right ventricular volume in patients with pulmonary hypertension. J Thorac Imaging. 1993; 8: 92– 7.
Search in Google Scholar Back to article
Swift AJ , Rajaram S , Condliffe R , Diagnostic accuracy of cardiovascular magnetic resonance imaging of right ventricular morphology and function in the assessment of suspected pulmonary hypertension: results from the ASPIRE registry. J Cardiovasc Magn Reson. 2012 Jun 21; 14: 40.
Search in Google Scholar Back to article
Peacock AJ , Crawley S , McLure L , Changes in right ventricular function measured by cardiac magnetic resonance imaging in patients receiving pulmonary arterial hypertension-targeted therapy: the EURO-MR study. Circ Cardiovasc Imaging. 2014 Jan; 7 1: 107– 14.
Search in Google Scholar Back to article
Trip P , Nossent EJ , de Man FS , Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses. Eur Respir J. 2013 Dec; 42 6: 1575– 85.
Search in Google Scholar Back to article
Sun XG , Hansen JE , Oudiz RJ , Wasserman K. Pulmonary function in primary pulmonary hypertension. J Am Coll Cardiol. 2003 Mar 19; 41 6: 1028– 35.
Search in Google Scholar Back to article
Jilwan FN , Escourrou P , Garcia G , Jaïs X , Humbert M , Roisman G. High occurrence of hypoxemic sleep respiratory disorders in precapillary pulmonary hypertension and mechanisms. Chest. 2013 Jan; 143 1: 47– 55.
Search in Google Scholar Back to article
Rafanan AL , Golish JA , Dinner DS , Hague LK , Arroliga AC. Nocturnal hypoxemia is common in primary pulmonary hypertension. Chest. 2001 Sep; 120 3: 894– 9.
Search in Google Scholar Back to article
Barst R , Lewis R , Long W , A comparison of continuous intravenous epoprostenol with conventional therapy for primary pulmonary hypertension. N Engl J Med. 1996 Feb 1; 334 5: 296– 301.
Search in Google Scholar Back to article
Galiè N , Corris PA , Frost A , Updated treatment algorithm of pulmonary arterial hypertension. J Am Coll Cardiol. 2013 Dec 24; 62 25 Suppl: D60– 72.
Search in Google Scholar Back to article
Simonneau G , Barst RJ , Galiè N , Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension. Am J Respir Crit Care Med. 2002; 165: 800– 4.
Search in Google Scholar Back to article
Mather M , McDevitt S , Saggar R. Subcutaneous treprostinil in pulmonary arterial hypertension: practical considerations. J Heart Lung Transplant. 2010 Nov; 29 11: 1210– 7.
Search in Google Scholar Back to article
Tapson VF , Gomberg-Maitland M , McLaughlin V , Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: a prospective, multicenter, open-label, 12-week trial. Chest. 2006 Mar; 129 3: 683– 8.
Search in Google Scholar Back to article
McLaughlin VV , Benza RL , Rubin LJ , Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial. J Am Coll Cardiol. 2010 May 4; 55 18: 1915– 22.
Search in Google Scholar Back to article
Jing ZC , Parikh K , Pulido T , Efficacy and safety of oral treprostinil monotherapy for the treatment of pulmonary arterial hypertension: a randomized, controlled trial. Circulation. 2013 Feb 5; 127 5: 624– 33.
Search in Google Scholar Back to article
Tapson VF , Jing ZC , Xu KF , Oral treprostinil for the treatment of pulmonary arterial hypertension in patients receiving background endothelin receptor antagonist and phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C2 study): a randomized controlled trial. Chest. 2013 Sep; 144 3: 952– 8.
Search in Google Scholar Back to article
Olschewski H , Simonneay G , Galiè N , Inhaled iloprost for severe pulmonary hypertension. N Engl J Med. 2002 Aug 1; 347 5: 322– 9.
Search in Google Scholar Back to article
Mubarak KK. A review of prostaglandin analogs in the management of patients with pulmonary arterial hypertension. Respir Med. 2010 Jan; 104 1: 9– 21.
Search in Google Scholar Back to article
Kuwano K , Hashino A , Asaki T , 2-[4-[(5,6-diphenylpyrazin-2-yl) (isopropyl)amino]butoxy]-N-(methylsulfonyl)acetamide (NS-304), an orally available and long-acting prostacyclin receptor agonist prodrug. J Pharmacol Exp Ther. 2007 Sep; 322 3: 1181– 8.
Search in Google Scholar Back to article
Simonneau G , Lang I , Torbicki A , Efficacy, safety, and tolerability of ACT-293987, a novel oral, non-prostanoid, prostaglandin I2 (IP) receptor agonist: results from a phase IIa study in pulmonary arterial hypertension (PAH). Am J Respir Crit Care Med. 2010; 181: A2515.
Search in Google Scholar Back to article
Sitbon O , Channick R , Chin KM , Selexipag for the Treatment of Pulmonary Arterial Hypertension. N Engl J Med. 2015 Dec 24; 373 26: 2522– 33.
Search in Google Scholar Back to article
Rubin LJ , Badesch DB , Barst RJ , Bosentan therapy for pulmonary arterial hypertension. N Engl J Med. 2002 Mar 21; 346 12: 896– 903.
Search in Google Scholar Back to article
Galiè N , Olschewski H , Oudiz R , Ambrisentan for the treatment of pulmonary arterial hypertension. Results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2. Circulation. 2008 Jun 10; 117 23: 3010– 9.
Search in Google Scholar Back to article
Pulido T , Adzerikho I , Channick RN , Macitentan and morbidity and mortality in pulmonary arterial hypertension. N Engl J Med. 2013 Aug 29; 369 9: 809– 18.
Search in Google Scholar Back to article
Channick RN , Delcroix M , Ghofrani HA , Effect of macitentan on hospitalizations: results from SERAPHIN trial. JACC Heart Fail. 2015 Jan; 3 1: 1– 8.
Search in Google Scholar Back to article
Galiè N , Ghofrani HA , Torbicki A , .; Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med. 2005 Nov 17; 353 20: 2148– 57.
Search in Google Scholar Back to article
Galiè N , Brundage BH , Ghofrani HA , Tadalafil therapy for pulmonary arterial hypertension. Circulation. 2009 Jun 9; 119 22: 2894– 903.
Search in Google Scholar Back to article
Mathai SC , Hassoun PM , Puhan MA. Sex differences in response to tadalafil in pulmonary arterial hypertension. Chest. 2015 Jan; 147 1: 188– 97.
Search in Google Scholar Back to article
Gabler NB , French B , Strom BL. Race and sex differences in response to endothelin receptor antagonists for pulmonary arterial hypertension. Chest. 2012 Jan; 141 1: 20– 6.
Search in Google Scholar Back to article
Ghofrani HA , Galiè N , Grimminger F , Riociguat for the treatment of pulmonary arterial hypertension. N Engl J Med. 2013 Jul 25; 369 4: 330– 40.
Search in Google Scholar Back to article
Ghofrani HA , Hoeper MM , Halank M , Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study. Eur Respir J. 2010 Oct; 36 4: 792– 9.
Search in Google Scholar Back to article
Rich S , Kaufmann E , Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med. 1992 Jul 9; 327 2: 76– 81.
Search in Google Scholar Back to article
Badesch DB , Abman SH , Ahearn GS , Medical therapy for pulmonary arterial hypertension. ACCP evidence-based clinical practice guidelines. Chest. 2004 Jul; 126 1 Suppl: 35S– 62S.
Search in Google Scholar Back to article
Barst RJ , Gibbs SR , Hossein A , Updated evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol. 2009 Jun 30; 54 1 Suppl: S78– 84.
Search in Google Scholar Back to article
Sitbon O , Humbert M , Jais X , Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation. 2005 Jun 14; 111 23: 3105– 11.
Search in Google Scholar Back to article
Taichman DB , Ornelas J , Chung L , Pharmacologic therapy for pulmonary hypertension in adults: CHETS guideline and expert panel report. Chest. 2014 Aug; 146 2: 449– 75.
Search in Google Scholar Back to article
Galiè N , Barbera J , Frost W , Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension. N Engl J Med. 2015 Aug 27; 373: 834– 44.
Search in Google Scholar Back to article
Hemnes AR , Kiely DG , Cockrill BA , Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute. Pulm Circ. 2015 Sep; 5 3: 435– 65.
Search in Google Scholar Back to article
Jaïs X , Olsson KM , Barberà JA , Pregnancy outcomes in pulmonary arterial hypertension in the modern management era. Eur Respir J. 2012 Oct; 40 4: 881– 5.
Search in Google Scholar Back to article
Lund CJ Donovan JC. Blood volume during pregnancy: significance of plasma and red cell volumes. Am J Obstetr Gynecol. 1967 Jun 1; 98 3: 393– 403.
Search in Google Scholar Back to article
Robson SC , Hunter S , Moore M , Dunlop W. Haemodynamic changes during the puerperium: a Doppler and M-mode echocardiographic study. Br J Obstetr Gynaecol. 1987 Nov; 94 11: 1028– 39.
Search in Google Scholar Back to article
Lahm T , Patel KM , Crisostomo PR , Endogenous estrogen attenuates pulmonary artery vasoreactivity and acute hypoxic pulmonary vasoconstriction: the effects of sex and menstrual cycle. Am J Physiol Endocrinol Metab. 2007 Jun 26; 293 3: E865– E871.
Search in Google Scholar Back to article
Mantha S , Karp R , Raghavan V , Terrin N , Bauer KA , Zwicker JI. Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis. BMJ. 2012 Aug 7; 345: e4944.
Search in Google Scholar Back to article
Regitz-Zagrosek V , Lundqvist CB , Borghi C , ESC guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011 Dec; 32 24: 3147– 97.
Search in Google Scholar Back to article
Terek D , Kayikcioglu M , Kultursay H , Pulmonary arterial hypertension and pregnancy. J Res Med Sci. 2013 Jan; 18 1: 73– 6.
Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.14797/mdcj-13-4-224 | Journal eISSN: 1947-6108

Journal RSS Feed

Language: English

Page range: 224 - 237

Published on: Oct 1, 2017

Published by: Houston Methodist DeBakey Heart & Vascular Center

In partnership with: Paradigm Publishing Services

Keywords:

pulmonary artery hypertension,

hypertension,

women,

pregnancy

© 2017 Humna Abid Memon, Myung H. Park, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.

Volume 13 (2017): Issue 4